Can I take Disudrin and Montelukast together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Take Disudrin with Montelukast?

Yes, you can safely take Disudrin (a combination decongestant/antihistamine) together with montelukast, as there are no clinically significant drug interactions between these medications. 1, 2

Safety Profile of the Combination

The combination of montelukast with common cold/allergy medications containing decongestants and antihistamines is well-established as safe:

  • No contraindications exist for concurrent use of montelukast with typical over-the-counter cold medications containing acetaminophen, decongestants (like pseudoephedrine or phenylephrine), and antihistamines. 1, 2

  • Clinical guidelines from the American Academy of Allergy, Asthma, and Immunology confirm there are no significant drug interactions of clinical concern between common pain relievers/decongestants and montelukast. 1

  • The FDA drug label for montelukast documents extensive drug interaction studies showing no clinically significant interactions with antihistamines (specifically terfenadine and fexofenadine were studied). 3

Therapeutic Benefits of Combined Use

This combination can actually provide complementary benefits:

  • Montelukast provides continuous control of allergic inflammation and asthma symptoms when taken daily, while Disudrin addresses acute nasal congestion and allergy symptoms. 2

  • For patients with both allergic rhinitis and asthma, combination therapy with montelukast plus antihistamines provides better symptom control than either medication alone. 1, 4

  • Studies demonstrate that montelukast combined with antihistamines like loratadine or cetirizine produces greater efficacy than when these agents are used alone, sometimes achieving results comparable to intranasal corticosteroids. 4

Important Considerations

No Dose Adjustments Required

  • No modifications to either medication's dosage are necessary when used together in patients with normal liver and kidney function. 2

Montelukast-Specific Warnings

  • Be aware of the FDA black box warning for montelukast regarding potential neuropsychiatric events (mood changes, depression, suicidal thoughts). Monitor for unusual behavioral or mood symptoms when taking this medication. 5, 2

  • The FDA issued this boxed warning in March 2020, and while montelukast remains available, clinicians should carefully weigh benefits versus risks, particularly in patients with psychiatric history. 5

Timing and Administration

  • Montelukast should be taken in the evening based on its pharmacodynamic profile, while Disudrin can be taken as directed on its label (typically during the day for daytime formulations). 6, 2

  • Both medications can be taken without regard to food, though taking with meals may improve gastrointestinal tolerability. 6

Tolerability Profile

The safety of this combination is supported by extensive clinical experience:

  • Montelukast has been studied in over 2 million patients worldwide with an adverse event profile similar to placebo in both short-term and long-term use. 7, 8

  • Common side effects of montelukast (headache, upper respiratory infection) occur at rates not statistically different from placebo. 7, 8

  • No dose-related adverse effects were observed even at doses up to 200 mg daily (20 times the standard dose) in clinical trials. 8

References

Guideline

Potential Interactions Between Contra Caps, Antihistamines, and Montelukast

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Montelukast and DayQuil Interaction Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Recommended Dosage of Levocetirizine and Montelukast Combination for Pediatric Age Groups

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.